Список проголосовавших за комментарий " Filings, Offerings and Pricings<p><strong>Filings:</strong></p><ul><li>Aeterna Zentaris (<strong>AEZS</strong>) files for $50 mln common share offering</li><li>Aralez Pharma (<strong>ARLZ</strong>) files to withdraw Registration Statement on Form S-1 (on Form S-3 as amended)</li><li>Checkpoint Therapeutics (<strong>CKPT</strong>) files for $50 mln offering of common stock</li><li>Daseke (<strong>DSKE</strong>) files for mixed securities offering</li><li>First Mid-Illinois Bancshares (<strong>FMBH</strong>) files for $60 mln mixed securities shelf offering</li><li>Pennant Investment (<strong>PNNT</strong>) files for $750 mln mixed securities shelf offering</li><li>Taylor Morrison Home (<strong>TMHC</strong>) files for mixed securities shelf offering; size not disclosed</li></ul><p><strong>Offerings:</strong></p><ul><li>Adaptimmune Therapeutics (<strong>ADAP</strong>) to offer and sell ADSs in underwritten public offering</li><li>Taylor Morrison Home (<strong>TMHC</strong>) commences an underwritten public offering of 10 mln shares of its Class A common stock</li><li>Vital Therapies (<strong>VTL</strong>) to offer to sell shares of its common stock in an underwritten public offering; size not disclosed</li></ul><p><strong>Pricings:</strong></p><ul><li>Calithera Biosciences (<strong>CALA 10.55</strong>) prices 6.83 mln common stock offering at $10.25/share</li><li>Easterly Government Properties (<strong>DEA 19.73</strong>) prices 4.3 mln common stock offering, all offered in connection with the forward sales agreements, at $19.00/share</li><li>Imprimis Pharma (<strong>IMMY 2.42</strong>) entered into agreements with two accredited investors for a registered direct placement of 1,312,000 shares of common stock at a price of $2.40 per share</li><li>REGENXBIO (<strong>RGNX 22.10</strong>) prices offering of 3.7 mln shares of common stock at $20.50 per share</li></ul>"